# FDA Inspection 946004 - Glaxo Wellcome S.A. - September 25, 2015

Source: https://www.keypedia.com/records/fda_inspections/glaxo-wellcome-sa/0a29d832-9c02-4031-ac4f-da37f23d0793
Source feed: FDA_Inspections

> FDA Inspection 946004 for Glaxo Wellcome S.A. on September 25, 2015. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 946004
- Company Name: Glaxo Wellcome S.A.
- Inspection Date: 2015-09-25
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1259789 - 2022-06-08](https://www.keypedia.com/records/fda_inspections/glaxo-wellcome-sa/49f54725-7ae2-407a-b5c4-5686c40428b6)
- [FDA Inspection 857625 - 2013-09-27](https://www.keypedia.com/records/fda_inspections/glaxo-wellcome-sa/798b3f3c-3927-4510-b175-ac351d49dc75)
- [FDA Inspection 673010 - 2010-06-24](https://www.keypedia.com/records/fda_inspections/glaxo-wellcome-sa/edce4456-cbc9-4850-84ab-644c6a47a97d)

Company: https://www.keypedia.com/companies/glaxo-wellcome-sa/fdbce0bc-69dc-4ed5-892d-05eb10376370

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c